• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY AG OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY AG OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number VKMO 78000
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Death (1802); Cardiac Enzyme Elevation (1838)
Event Type  Death  
Manufacturer Narrative
(b)(4). A follow-up medwatch will be submitted when additional information becomes available.
 
Event Description
According to the hospital: "during operation of a patient; decrease in albumin levels, increase in both urea creatinine and liver enzyme level had been occurred. The patient had died on unknown dates in post-op period. Due to the event, the hospital does not want to use the batches. There is no absolute doubt on the product in relation with death. It has been reported that an investigation done for all the products used in the operations. " (b)(4).
 
Manufacturer Narrative
The available information has been shared internally with the getinge (b)(6). It was stated that with the data provided in the case, it is impossible to find out any relationship between the device and the reported event. There is no direct association between increased renal and liver parameter and use of the devices in the case. The investigation report does not show abnormalities either. Due to the limited information available, a more comprehensive and detailed clinical assessment is not possible. A dhr review was performed based on the available information. The dhr of the affected lot 70107389 and packaging lot 70108586 (serial number (b)(4)) was inspected. The (b)(4) was reviewed. There were no references found, which are indicating a nonconformance of the product. The reported set was discarded by the hospital. However, the set(after priming process) was sent as a complaint sample which has not been used with any patient. Laboratory investigation results are still pending. Maquet cardiopulmonary (b)(4) will submit a supplemental medwatch on receipt of further information.
 
Event Description
(b)(4).
 
Manufacturer Narrative
The claimed set was thrown away by the hospital. However, the set (after priming process) was sent as a complaint sample which has not been used with any patient. The set was examined visually by our laboratory. The oxygenator was rinsed with water and no abnormalities detected. The product was forwarded to the qa lab for further testing. In the qa laboratory, the product was tested for its gas exchange performance for o2 and co2, and also a pressure drop test was performed. The product passed all the performance tests and found to be working as specified. A sap trend search has been performed (search for material (b)(4)), which came to following results:no additional complaints were recorded. Based on the trending, a systemic issue is not indicated. The most probable cause of the failure is unknown at this time. According to the information available at this time, a malfunction of the product cannot be confirmed. Based on the investigation and trending for this issue, neither a product malfunction nor a systemic issue is indicated, therefore no further investigation or action is currently warranted in addition to continued periodic monitoring, and the complaint will be closed. This data will be handled through a designated maquet trending process. If at trend occurs, it will be escalated to quality assurance management for review and determination if further investigation is necessary. Due to this no further action will be completed at this time.
 
Event Description
Ref. : #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameOXYGENATOR, CARDIOPULMONARY BYPASS
Type of DeviceOXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY AG
rastatt
GM
Manufacturer (Section G)
BERND RAKOW
maquet cardiopulmonary ag
kehler strasse 31
76437 rastatt
GM
Manufacturer Contact
maquet cardiopulmonary ag
kehler strasse 31
76437 rastatt 
4972229321
MDR Report Key6409622
MDR Text Key70105598
Report Number8010762-2017-00085
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K082117
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation
Type of Report Initial,Followup,Followup
Report Date 08/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/16/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date12/06/2017
Device Model NumberVKMO 78000
Device Catalogue Number701067941
Device Lot Number92178828
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/08/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received02/21/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 03/16/2017 Patient Sequence Number: 1
-
-